The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Cardiovascular Disease Risk High in RA Patients

Cardiovascular Disease Risk High in RA Patients

June 1, 2010 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The NCEP (National Cholesterol Education Program) Adult Treatment Panel III criteria for metabolic syndrome include the following, and three of the five must be present for a diagnosis of metabolic syndrome:

You Might Also Like
  • Depression May Increase Risk of Cardiovascular Disease for RA Patients
  • Foundation Research Explores Relationship Between RA and Cardiovascular Disease
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA
Explore This Issue
June 2010
Also By This Author
  • Is It Time to Replace the HAQ?
  • Waist circumference: >40.2 inches in men; >34.6 inches in women
  • Triglycerides: >150 mg/dL
  • HDL cholesterol: <40 mg/dL in men; <50 mg/dL in women
  • Blood pressure: >130/85 mm Hg
  • Fasting plasma glucose: >110 mg/dL

Several factors are associated with insulin resistance in patients with RA, according to Dr. Giles, who is assistant professor of medicine in the division of rheumatology at Johns Hopkins University in Baltimore. These factors include macronutrient excess, often accompanied by less physical activity; obesity, whether overt or preferential partitioning; inflammation, with more RA-derived cytokines; and glucocorticoid use.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Other metabolic syndrome criteria also tend to be over-represented in RA: waist girth, hypertension, hypertriglyceridemia, low HDL cholesterol, and hyperglycemia.6

Predictors of insulin resistance in RA include increasing current prednisone use, decreasing HDL cholesterol, and increasing truncal fat mass as measured by a dual-energy X-ray absorptiometry scan. Rheumatoid factor seropositivity and cumulative prednisone dose have been linked with higher visceral fat in patients with RA, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There is “no current evidence that any particular pharmacologic agent decreases cardiovascular risk by reversing insulin resistance in any rheumatic disease,” Dr. Giles said. Instead, primary efforts to reduce insulin resistance should focus on fat reduction, given the central role of visceral fat in insulin resistance.

“Maintaining a healthy body composition should be emphasized even early in disease, along with constant reappraisal of the need to continue glucocorticoids,” he said.

Kathy Holliman is a medical journalist based in New Jersey.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Sattar N, McInnes IB. Vascular comorbidity in rheumatoid arthritis: Potential mechanisms and solution. Curr Opin Rheumatol. 2005;17:286-292.
  2. Choi HK, Heman M, Seeger J, Robins J, Wolfe F. Methotrexate therapy and mortality in patients with rheumatoid arthritis. Lancet. 2002;359:1173-1177.
  3. Reiss AB, Carsons SE, Anwar K, et al. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis Rheum. 2008;58:3675-3683.
  4. McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): Double-blind, randomised placebo-controlled trial. Lancet. 2004;363: 2015-2021.
  5. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006; 54:2541-2549.
  6. Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756-763.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Guidelines, Rheumatoid Arthritis Tagged With: Cardiovascular disease, inflammation, Rheumatoid arthritisIssue: June 2010

You Might Also Like:
  • Depression May Increase Risk of Cardiovascular Disease for RA Patients
  • Foundation Research Explores Relationship Between RA and Cardiovascular Disease
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.